- Knowledge, Attitudes and Perceptions of Genetic Testing Among Patients With Movement Disorders, Their Caregivers and Health Care Professionals
-
Kamath SD, Holla VV, Kamble N, Mahale RR, Yadav R, Pal PK
- KMID: 2558080
- J Mov Disord.
- 2024 Jul;17(3):336-338.
- doi: 10.14802/jmd.24034
-
- CITED
-
- Close
- SHARE
-
- Close
- Tremulous Dystonia Due to GNAL Haploinsufficiency Caused by 18p Deletion Syndrome
-
Braccia A, Carecchio M, Sciacca FL, Castagna A, Elia AE, Romito LM
- KMID: 2558086
- J Mov Disord.
- 2024 Jul;17(3):354-356.
- doi: 10.14802/jmd.24080
-
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 Vaccine-Related Movement Disorders: A Systematic Review
-
Angeles GED, Dichoso LPC, Jamora RDG
- KMID: 2558077
- J Mov Disord.
- 2024 Jul;17(3):322-327.
- doi: 10.14802/jmd.24001
Objective Since the release of vaccines against coronavirus disease 2019 (COVID-19), there have been reports of vaccine-related neurologic complications. This study aimed to perform a descriptive systematic review of movement... -
- CITED
-
- Close
- SHARE
-
- Close
- Functional Movement Disorders: Updates and Clinical Overview
-
Park JE
- KMID: 2558070
- J Mov Disord.
- 2024 Jul;17(3):251-261.
- doi: 10.14802/jmd.24126
Functional movement disorder (FMD) is a type of functional neurological disorder that is common but often difficult to diagnose or manage. FMD can present as various phenotypes, including tremor, dystonia,... -
- CITED
-
- Close
- SHARE
-
- Close
- Tremors in Infantile Tremor Syndrome Mimicking Epilepsia Partialis Continua
-
Gailson T, Gunasekaran PK, Saini AG, Reddy C
- KMID: 2558085
- J Mov Disord.
- 2024 Jul;17(3):351-353.
- doi: 10.14802/jmd.24074
-
- CITED
-
- Close
- SHARE
-
- Close
- Haloperidol in Managing DYT-TOR1A Dystonia: Unveiling a Dramatic Therapeutic Response
-
Katragadda P, Holla VV, Kamble N, Yadav R, Pal PK
- KMID: 2558082
- J Mov Disord.
- 2024 Jul;17(3):342-344.
- doi: 10.14802/jmd.24029
-
- CITED
-
- Close
- SHARE
-
- Close
- Adult-Onset Alexander Disease With Late-Presenting Vestibulopathy: A Case Report
-
Chang HJ, Jeong SH, Oh E
- KMID: 2558088
- J Mov Disord.
- 2024 Jul;17(3):360-363.
- doi: 10.14802/jmd.23230
-
- CITED
-
- Close
- SHARE
-
- Close
- Dopamine Dysregulation Syndrome Presenting as Overuse of Mucuna pruriens Levodopa Supplement
-
Sohutskay DO, Suen RM, Ali F, Rosenman DJ
- KMID: 2558087
- J Mov Disord.
- 2024 Jul;17(3):357-359.
- doi: 10.14802/jmd.24067
-
- CITED
-
- Close
- SHARE
-
- Close
- Dystonic Cerebral Palsy-Like Presentation Caused by a Novel TCF20 Variant
-
Prasun P, Vermeire K, Ferimer S
- KMID: 2558084
- J Mov Disord.
- 2024 Jul;17(3):348-350.
- doi: 10.14802/jmd.24007
-
- CITED
-
- Close
- SHARE
-
- Close
- Deep Brain Stimulation in Advanced Parkinson’s Disease: An Uncommon Case of Allergic Encephalitis
-
Chen JY, Chen YC, Wu SL
- KMID: 2558083
- J Mov Disord.
- 2024 Jul;17(3):345-347.
- doi: 10.14802/jmd.23237
-
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Strategy for Improving Motor Complications of Parkinson’s Disease: Short-Term Levodopa–Carbidopa Intestinal Gel Therapy Using a Nasogastric Tube
-
Taguchi S, Nakura T, Doyu M, Saiki H
- KMID: 2558079
- J Mov Disord.
- 2024 Jul;17(3):333-335.
- doi: 10.14802/jmd.24033
-
- CITED
-
- Close
- SHARE
-
- Close
- The First East Asian Patient With Parkinson’s Disease Caused by the A53E SNCA Mutation With Early Progression to Dementia
-
Yoon YJ, Park CW, Kim JJ, Chung SJ, Kim YJ
- KMID: 2558089
- J Mov Disord.
- 2024 Jul;17(3):364-367.
- doi: 10.14802/jmd.24118
-
- CITED
-
- Close
- SHARE
-
- Close
- Joubert Syndrome Presenting With Levodopa-Responsive Parkinsonism
-
Hwangbo J, Park KS, Kim HS, Choi JH, Lee JH
- KMID: 2558081
- J Mov Disord.
- 2024 Jul;17(3):339-341.
- doi: 10.14802/jmd.23275
-
- CITED
-
- Close
- SHARE
-
- Close
- Neurological Perspectives Should Be Integrated Into the Management of Tardive Dyskinesia—Expert Opinions and Proposed Educational Initiatives in Asia
-
Bhidayasiri R, Phokaewvarangkul O, Lim TT, Pal PK, Watanabe H, Cho JW, Shang HF
- KMID: 2558071
- J Mov Disord.
- 2024 Jul;17(3):262-269.
- doi: 10.14802/jmd.24068
-
- CITED
-
- Close
- SHARE
-
- Close
- The Impact of LRRK2 G2019S on Parkinson’s Disease: Clinical Phenotype and Treatment in Tunisian Patients
-
Barreh GA, Sghaier I, Abida Y, Gharbi A, Nasri A, Mrabet S, Souissi A, Djebara MB, Trabelsi S, Kacem I, Gargouri-Berrechid A, Gouider R
- KMID: 2558074
- J Mov Disord.
- 2024 Jul;17(3):294-303.
- doi: 10.14802/jmd.23276
Objective LRRK2-G2019S is the most frequent mutation in North African Parkinson’s disease (PD) patients. Data on its impact on disease progression and treatment response remain elusive. Therefore, we investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Structural Characteristics of NEU1 Variants Causing Sialidosis Type 1
-
Li Y, Liu Y, Wang R, Ao R, Xiang F, Zhang X, Wang X, Yu S
- KMID: 2558073
- J Mov Disord.
- 2024 Jul;17(3):282-293.
- doi: 10.14802/jmd.23145
Objective Sialidosis type 2 has variants that are both catalytically inactive (severe), while sialidosis type 1 has at least one catalytically active (mild) variant. This study aimed to discuss the... -
- CITED
-
- Close
- SHARE
-
- Close
- Fatigue in Parkinson’s Disease Is Due to Decreased Efficiency of the Frontal Network: Quantitative EEG Analysis
-
Kim MS, Park S, Park U, Kang SW, Kang SY
- KMID: 2558075
- J Mov Disord.
- 2024 Jul;17(3):304-312.
- doi: 10.14802/jmd.24038
Objective Fatigue is a common, debilitating nonmotor symptom of Parkinson’s disease (PD), but its mechanism is poorly understood. We aimed to determine whether electroencephalography (EEG) could objectively measure fatigue and... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluating the Validity and Reliability of the Korean Version of the Scales for Outcomes in Parkinson’s Disease–Cognition
-
Park J, Oh E, Koh SB, Song IU, Ahn TB, Kim SJ, Cheon SM, Kim YJ, Cho JW, Ma HI, Park MY, Baik JS, Lee PH, Chung SJ, Kim JM, Kim HJ, Sung YH, Kwon DY, Lee JH, Lee JY, Kim JS, Yun JY, Kim HJ, Hong JY, Kim MJ, Youn J, Yang HJ, Yoon WT, You S, Kwon KY, Lee SY, Kim Y, Kim HT, Kim JS, Kim JY
- KMID: 2558078
- J Mov Disord.
- 2024 Jul;17(3):328-332.
- doi: 10.14802/jmd.24061
Objective The Scales for Outcomes in Parkinson’s Disease–Cognition (SCOPA-Cog) was developed to assess cognition in patients with Parkinson’s disease (PD). In this study, we aimed to evaluate the validity and... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in Physiotherapy Interventions and Medical Costs for Parkinson’s Disease in South Korea, 2011–2020
-
Ryu DW, Park J, Lee MJ, Yoo D, Cheon SM
- KMID: 2558072
- J Mov Disord.
- 2024 Jul;17(3):270-281.
- doi: 10.14802/jmd.23269
Objective Physiotherapy (PT), which is an effective strategy for managing Parkinson’s disease (PD), can influence health care utilization. We analyzed trends in health care utilization, PT interventions, and medical costs... -
- CITED
-
- Close
- SHARE
-
- Close
- Association Between Exposure to Particulate Matter and the Incidence of Parkinson’s Disease: A Nationwide Cohort Study in Taiwan
-
Chen TB, Liang CS, Chang CM, Yang CC, Yu HL, Wu YS, Huang WJ, Tsai IJ, Yan YH, Wei CY, Yang CP
- KMID: 2558076
- J Mov Disord.
- 2024 Jul;17(3):313-321.
- doi: 10.14802/jmd.24003
Objective Emerging evidence suggests that air pollution exposure may increase the risk of Parkinson’s disease (PD). We aimed to investigate the association between exposure to fine particulate matter (PM2.5) and... -
- CITED
-
- Close
- SHARE
-
- Close
